Supplement AER Compliance Costs Exceed FDA Estimates – Industry
This article was originally published in The Tan Sheet
Executive Summary
FDA’s estimate of supplement AER costs does not consider that firms must thoroughly investigate and evaluate all reports to determine whether they are serious and maintain records of reports, industry trade groups say.
You may also be interested in...
Supplement AER Under-Reporting Marks Tip Of Compliance Iceberg – FDA
FDA’s dietary supplement program chief raised eyebrows at a botanical products conference citing low estimates on rates of compliance with the good manufacturing practices final rule and the new dietary ingredient notification requirements, as well as adverse event reporting.
FDA “Undercuts” NDI Guidance Opposition With Compliance Cost Estimate – CRN
OMB approves FDA’s estimate as the official measure for the supplement industry’s anticipated burden in complying with the NDI notification regulation.
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.